StockWatch
·
Biotechnology: Pharmaceutical Preparations
InvestmentApr 21, 2026, 08:06 AM

Pulmatrix Closes Private Placement of Series B Preferred Stock

AI Summary

Pulmatrix, Inc. announced the closing of its previously disclosed private placement of Series B Preferred Stock on April 16, 2026. The transaction was conducted under exemptions from registration requirements, specifically Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D. A press release regarding the closing was issued on April 21, 2026.

Key Highlights

  • Pulmatrix closed its previously announced private placement.
  • The private placement involved Series B Preferred Stock.
  • The transaction closed on April 16, 2026.
  • It was exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D.